
Nelson C. Holtje
Examiner (ID: 10293)
| Most Active Art Unit | 2913 |
| Art Unit(s) | 2913, 2912, 2900, 2903, 2899, 2702, 2902 |
| Total Applications | 5859 |
| Issued Applications | 5818 |
| Pending Applications | 1 |
| Abandoned Applications | 40 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11492922
[patent_doc_number] => 20170067107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'GENE EXPRESSION BASED BIOMARKER SYSTEM FOR IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/120941
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11170
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120941 | Gene expression based biomarker system for irritable bowel syndrome (IBS) diagnosis | Feb 23, 2015 | Issued |
Array
(
[id] => 11692343
[patent_doc_number] => 20170168059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'BIOMARKERS FOR ASSESSING CANCER PATIENTS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/116925
[patent_app_country] => US
[patent_app_date] => 2015-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 18217
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116925
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/116925 | BIOMARKERS FOR ASSESSING CANCER PATIENTS FOR TREATMENT | Feb 8, 2015 | Abandoned |
Array
(
[id] => 11312072
[patent_doc_number] => 20160348182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'METHODS AND KITS FOR THE DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/116272
[patent_app_country] => US
[patent_app_date] => 2015-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20919
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 54
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116272
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/116272 | Methods and kits for the diagnosis and treatment of pancreatic cancer | Feb 3, 2015 | Issued |
Array
(
[id] => 10340787
[patent_doc_number] => 20150225792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING DEPRESSIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/598975
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15614
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598975
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/598975 | COMPOSITIONS AND METHODS FOR IDENTIFYING DEPRESSIVE DISORDERS | Jan 15, 2015 | Abandoned |
Array
(
[id] => 10333635
[patent_doc_number] => 20150218639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'BIOMARKERS PREDICTIVE OF PREDISPOSITION TO DEPRESSION AND RESPONSE TO TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/598970
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16429
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598970
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/598970 | BIOMARKERS PREDICTIVE OF PREDISPOSITION TO DEPRESSION AND RESPONSE TO TREATMENT | Jan 15, 2015 | Abandoned |
Array
(
[id] => 11325272
[patent_doc_number] => 20160355885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'GENE METHYLATION BASED COLORECTAL CANCER DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/106578
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9897
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/106578 | GENE METHYLATION BASED COLORECTAL CANCER DIAGNOSIS | Dec 18, 2014 | Abandoned |
Array
(
[id] => 10282092
[patent_doc_number] => 20150167090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'DIAGNOSIS AND PROGNOSIS OF SEVERITY OF AUTISM SPECTRUM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/576092
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11839
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576092
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/576092 | Diagnosis and prognosis of severity of autism spectrum disorders | Dec 17, 2014 | Issued |
Array
(
[id] => 11115324
[patent_doc_number] => 20160312297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'PD-L1 GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/104539
[patent_app_country] => US
[patent_app_date] => 2014-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22948
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104539
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104539 | PD-L1 GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS | Dec 14, 2014 | Abandoned |
Array
(
[id] => 11115321
[patent_doc_number] => 20160312295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/104000
[patent_app_country] => US
[patent_app_date] => 2014-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25513
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104000
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104000 | GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS | Dec 14, 2014 | Abandoned |
Array
(
[id] => 11107999
[patent_doc_number] => 20160304969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'IFN-GAMMA GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/104245
[patent_app_country] => US
[patent_app_date] => 2014-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23438
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104245
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104245 | IFN-GAMMA GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS | Dec 14, 2014 | Abandoned |
Array
(
[id] => 12212383
[patent_doc_number] => 09909181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Biomarkers for post-traumatic stress states'
[patent_app_type] => utility
[patent_app_number] => 14/569127
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12906
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14569127
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/569127 | Biomarkers for post-traumatic stress states | Dec 11, 2014 | Issued |
Array
(
[id] => 10282103
[patent_doc_number] => 20150167100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'Hereditary Cancer Genes'
[patent_app_type] => utility
[patent_app_number] => 14/567614
[patent_app_country] => US
[patent_app_date] => 2014-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26497
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14567614
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/567614 | Hereditary Cancer Genes | Dec 10, 2014 | Abandoned |
Array
(
[id] => 11115307
[patent_doc_number] => 20160312281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'METHODS AND PROBES FOR IDENTIFYING GENE ALLELES'
[patent_app_type] => utility
[patent_app_number] => 15/102474
[patent_app_country] => US
[patent_app_date] => 2014-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8473
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102474
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/102474 | METHODS AND PROBES FOR IDENTIFYING GENE ALLELES | Dec 9, 2014 | Abandoned |
Array
(
[id] => 10241385
[patent_doc_number] => 20150126380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'METHOD FOR ANALYZING MATERNAL DNA IN LARGE PLANT POPULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/562428
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9084
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562428
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562428 | Method for analyzing maternal DNA in large plant populations | Dec 4, 2014 | Issued |
Array
(
[id] => 18933399
[patent_doc_number] => 11885816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Personalized medicine approach for treating cognitive loss
[patent_app_type] => utility
[patent_app_number] => 15/037492
[patent_app_country] => US
[patent_app_date] => 2014-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 21335
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037492 | Personalized medicine approach for treating cognitive loss | Nov 25, 2014 | Issued |
Array
(
[id] => 16246412
[patent_doc_number] => 10745754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Method for predicting congenital heart defect
[patent_app_type] => utility
[patent_app_number] => 15/039589
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16329
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039589
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039589 | Method for predicting congenital heart defect | Nov 24, 2014 | Issued |
Array
(
[id] => 12963163
[patent_doc_number] => 09873908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Methods for the enrichment of mutated nucleic acid from a mixture
[patent_app_type] => utility
[patent_app_number] => 14/547899
[patent_app_country] => US
[patent_app_date] => 2014-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6355
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 300
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14547899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/547899 | Methods for the enrichment of mutated nucleic acid from a mixture | Nov 18, 2014 | Issued |
Array
(
[id] => 11068072
[patent_doc_number] => 20160265036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'METHODS FOR DETECTING NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/034831
[patent_app_country] => US
[patent_app_date] => 2014-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23205
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034831 | METHODS FOR DETECTING NUCLEIC ACIDS | Nov 4, 2014 | Abandoned |
Array
(
[id] => 10750946
[patent_doc_number] => 20160097097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'METHOD FOR DETERMINING P1/P2 BLOOD TYPE AND DETECTION KIT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/505493
[patent_app_country] => US
[patent_app_date] => 2014-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3975
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14505493
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/505493 | METHOD FOR DETERMINING P1/P2 BLOOD TYPE AND DETECTION KIT THEREOF | Oct 1, 2014 | Abandoned |
Array
(
[id] => 11025494
[patent_doc_number] => 20160222448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'METHOD TO ESTIMATE THE AGE OF TISSUES AND CELL TYPES BASED ON EPIGENETIC MARKERS'
[patent_app_type] => utility
[patent_app_number] => 15/025185
[patent_app_country] => US
[patent_app_date] => 2014-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 44444
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025185
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/025185 | METHOD TO ESTIMATE THE AGE OF TISSUES AND CELL TYPES BASED ON EPIGENETIC MARKERS | Sep 28, 2014 | Abandoned |